Texas stem cell rules may impede clinical research

Clinical Trials Monday, May 21st, 2012
The Lancet: by Carrie Arnold, May 12, 2012.
Stem cell researchers in the USA and abroad are reeling from new laws in Texas that commercialise experimental procedures and could attract patients away from clinical trials. Carrie Arnold reports.
New regulations on the experimental use of adult stem cells recently passed by the Texas Medical Board has returned the ethos of the Wild West to the Lone Star State. Supporters of the rules believe they offer patients seeking stem cell therapies a modicum of protection in a semi-lawless environment, but opponents believe that these regulations actually put patients at greater risk. What is more, critics say, these guidelines could actually hold back progress in stem cell research.
“I think it’s outrageous”, said Leigh Turner, a bioethicist from the University of Minnesota, MN, USA, who testified at the medical board’s hearings. “Some of what takes place may not be credible research. It’s going to be unproven interventions sold for profit with the veneer of a clinical trial.” Read more
National Minority Quality Forum Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.